Cytiva - About the company
Cytiva is a funded company based in Sheffield (United Kingdom), founded in 1968. It operates as a Provider of equipment and technology solutions for biopharmaceutical drug manufacturing. Cytiva has raised an undisclosed amount in funding. The company has 432 active competitors, including 42 funded and 57 that have exited. Its top competitors include companies like Siemens Healthineers, Illumina and Quanterix.
Company Details
Provider of equipment and technology solutions for biopharmaceutical drug manufacturing. The business supplies instrumentation, software, and consumables used in research, development, and commercial production of therapeutic products. Offerings include systems for protein analysis, cell culture, fermentation, bioprocess filtration, and aseptic filling. These products support workflows throughout the discovery, purification, and manufacturing stages of life sciences.
- Email ID
- *****@cytiva.com
- Phone Number
- +44 **********
- Registered Address
- Galileo, John F Welch Technology Centre, 122 EPIP Zone Phase II, Hoodi Village, White, field Road, Bangalore, Bangalore, Karnataka, India, 560066
Key Metrics
Founded Year
1968
Location
Sheffield, United Kingdom
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
20th among 432 active competitors
Annual Revenue
₹500 - ₹1,000 Cr as on Mar 31, 2025
Employee Count
578 as on Jan 31, 2025
Investment & Acquisitions
Similar Companies
Legal entities associated with Cytiva
Cytiva is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CYTIVA INDIA PRIVATE LIMITED CIN: U29100PN2022FTC210393 , India, Active | Apr 15, 2022 | ₹50 - ₹100 Cr (As on Mar 31, 2025) | 45 (As on Mar 01, 2026) | |
HYCLONE LIFE SCIENCES SOLUTIONS INDIA PRIVATE LIMITED CIN: U24304KA2019PTC126720 , India, Active | Aug 01, 2019 | ₹500 - ₹1,000 Cr (As on Mar 31, 2025) | 578 (As on Jan 31, 2025) |
Sign up to download Cytiva's company profile
Cytiva's funding and investors
Cytiva has raised funding over 2 rounds. Its first funding round was on May 24, 2019. Its latest funding round was a Grant (prize money) round on Oct 09, 2023 for $*****. 1 investor participated in its latest round. Cytiva has 1 institutional investor.
Here is the list of recent funding rounds of Cytiva:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 09, 2023 | 9716701 | Grant (prize money) | 9654756 | 9700854 | 4278539 | 6325977 |
May 24, 2019 | 8856803 | Grant (prize money) | 2514754 | 6470137 | 6182918 |
View details of Cytiva's funding rounds and investors
Cytiva's founders and board of directors
Founder? Claim ProfileCytiva's employee count trend
Cytiva has 578 employees as of Jan 25. The total employee count is 13.0% more than what it was in Jan 24. Here is Cytiva's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cytiva's Competitors and alternates
Top competitors of Cytiva include Siemens Healthineers, Illumina and Quanterix. Here is the list of Top 10 competitors of Cytiva, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Siemens Healthineers 2017, Forchheim (Germany), Public | Provider of medical imaging laboratory diagnostics and clinical digital solutions | - | 75/100 | |
2nd | Illumina 1993, San Diego (United States), Public | Developer of technologies for analysis of genetic variation and function | $28M | 71/100 | |
3rd | Quanterix 2007, Cambridge (United States), Public | Developer of assay kits for ultra-sensitive biomarker detection | $99.5M | 71/100 | |
4th | BioLife Solutions 1987, Bothell (United States), Acquired | Developer of cell and gene therapies with the integrity of a single cell | - | - | 67/100 |
5th | Biocare Medical 1997, Concord (United States), Acquired | Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | 65/100 | |
6th | Provider of gene sequencing instruments, reagents, equipment, and related products | $1B | 63/100 | ||
7th | Abselion 2018, Cambridge (United Kingdom), Series A | Provider of a benchtop instrument for protien research | $12.6M | 59/100 | |
8th | Applied BioCode 2008, Santa Fe Springs (United States), Public | Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications | $20.3M | 59/100 | |
9th | Bio Rad 1952, Hercules (United States), Public | Portfolio of products and services for life science research and clinical diagnostic markets | - | 58/100 | |
10th | Mapi Pharma 2008, Ness Ziona (Israel), Series B | Clinical stage pharmaceutical company developing extended release versions of generic drugs. | $60M | 56/100 | |
20th | Cytiva 1968, Sheffield (United Kingdom), Funding Raised | Provider of equipment and technology solutions for biopharmaceutical drug manufacturing | - | 50/100 |
Looking for more details on Cytiva's competitors? Click here to see the top ones
Cytiva's Investments and acquisitions
Cytiva has not made any investments yet. Cytiva has made 4 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 06, 2022 | Acquisition | 2001 | Cologne (Germany) | |
Jun 29, 2021 | Acquisition | 2014 | West Jordan (United States) | |
Jun 02, 2021 | Acquisition | 2016 | Karlsruhe (Germany) |
See all acquisitions by Cytiva
Reports related to Cytiva
Here is the latest report on Cytiva's sector:
News related to Cytiva
Media has covered Cytiva for a total of 9 events in the last 1 year, 3 of them have been about company updates and 3 about partnerships.
•
•
Rockwell Automation and Cytiva Launch Figurate SCADA Platform to Accelerate Biopharmaceutical Manufacturing Digital TransformationEuropean Pharmaceutical Manufacturer•May 07, 2026•Cytiva, Rockwell Automation
•
Thermo Fisher, SHL collab on drug delivery device productionDrug Delivery Business•Mar 25, 2026•SHL, Thermo Fisher Scientific, Cellular Origins, Cytiva and 1 other
•
Cytiva Sets Up Bioprocessing Center in Bengaluru for Drug DevelopmentBusiness Line•Feb 25, 2026•Cytiva
•
Cytiva, Fidabio Partner to Expand Analytical Capabilities for Protein ResearchContract Pharma•Dec 10, 2025•Cytiva, Fidabio
•
Cytiva unveils Fibro dT platform for enhanced mRNA purificationEuropean Pharmaceutical Manufacturer•Nov 11, 2025•Cytiva
•
Avantor appoints Mary Blenn as EVP, CEOSeeking Alpha•Nov 10, 2025•Cytiva, Avantor, Rosenlegal, Levi & Korsinsky and 4 others
•
REGENXBIO Completes Enrollment in Pivotal Trials for Surabgene Lomparvovec for Wet AMDPR Newswire•Oct 06, 2025•Regenxbio, Cytiva, GlobalData
•
Danaher and Shanghai biotech company announce strategic partnershipChina Daily•Jul 16, 2025•Danaher, Cytiva
•
Cytiva Completes Projects in Asia, US & Europe with $1.6 B Strategic InvestmentBioSpectrum Asia•Jun 13, 2025•Cytiva
Are you a Founder ?
FAQs about Cytiva
Explore our recently published companies
- Indian Soya Industries - Indore based, 1968 founded, Unfunded company
- Shri Krishna Automobiles - Faridabad based, 1954 founded, Unfunded company
- Mahalaxmi Steels - Mumbai based, 1980 founded, Unfunded company
- Kalpora - Gurugram based, 2025 founded, Unfunded company
- Sola Salon Studios - Denver based, 2004 founded, Acquired company
- Penna Seeds - Hyderabad based, 2004 founded, Unfunded company